Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration | Zendy

M. Díaz-Llopis | Zendy; Suelves-Cogollos | Zendy; E Frances-Munoz | Zendy; José M. Millán | Zendy; Arevalo | Zendy; Jose Mullor | Zendy; Roberto Gallego-Pinazo | Zendy

Open Access

Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration

Author(s) -

M. Díaz-Llopis,

Suelves-Cogollos,

E Frances-Munoz,

José M. Millán,

Arevalo,

Jose Mullor,

Roberto Gallego-Pinazo

Publication year - 2011

Publication title -

clinical ophthalmology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.025

H-Index - 56

eISSN - 1177-5483

pISSN - 1177-5467

DOI - 10.2147/opth.s15832

Subject(s) - macular degeneration , ranibizumab , medicine , choroidal neovascularization , ophthalmology , neovascularization , optometry , bevacizumab , surgery , angiogenesis , chemotherapy

The aim of our study was to evaluate the functional and anatomic outcomes of intravitreal ranibizumab for the treatment of symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research